Literature DB >> 8481544

The ethnic distribution of antibodies to glutamic acid decarboxylase: presence and levels of insulin-dependent diabetes mellitus in Europid and Asian subjects.

P Z Zimmet1, M J Rowley, I R Mackay, W J Knowles, Q Y Chen, L H Chapman, S W Serjeantson.   

Abstract

Our objective was to ascertain the frequency of antibodies to glutamic acid decarboxylase (GAD) in Europids and four Asian ethnic groups with insulin-dependent diabetes mellitus (IDDM) to gain insight into why the prevalence and incidence of IDDM varies so widely among ethnic and/or geographically diverse population groups. The subjects in this study were Europid (n = 49), Japanese (n = 16), Thai (n = 7), Korean (n = 21), and Chinese (n = 13) persons with IDDM with a duration ranging from 5 to 14 years. There were similar numbers of healthy controls matched for each ethnic group. A validated radioimmunoprecipitation assay used GAD from pig brain radiolabeled with 125I using chloramine T. Islet cell cytoplasmic antibodies measured by indirect immunofluorescence were expressed as Juvenile Diabetes Foundation units. The prevalence of antibodies to GAD, compared with Europids (63%), was much lower in all Asian populations with IDDM: Japanese (31%), Thai (29%), Korean (5%), and Chinese (27%). The mean level of antibodies to GAD, however, among diabetics from each population who gave a positive reaction, was similar. For all groups, the prevalence of antibodies to GAD was much higher than that of islet cell cytoplasmic antibodies. Almost all IDDM subjects positive for islet cell antibodies had antibodies to GAD, but the converse did not hold. A radioimmunoprecipitation assay for antibodies to GAD applied to serum from subjects with IDDM in various ethnic groups showed that Europids with IDDM had a much higher prevalence of such antibodies than did Asians. This held for all ethnic groups, and particularly Koreans. Thus, among different populations, there may be etiologic heterogeneity of IDDM.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8481544     DOI: 10.1016/1056-8727(93)90016-r

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  4 in total

1.  Islet cell, thyroid, adrenal and celiac disease related autoantibodies in patients with Type 1 diabetes from Sri Lanka.

Authors:  L D K E Premawardhana; C N Wijeyaratne; S Chen; M Wijesuriya; U Illangasekera; H Brooking; M Amoroso; J Jeffreys; J Bolton; J H Lazarus; J Furmaniak; B Rees Smith
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

Review 2.  Interferon therapy in hepatitis C leading to chronic type 1 diabetes.

Authors:  Taiba Zornitzki; Stephen Malnick; Lyudmila Lysyy; Hilla Knobler
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

3.  Prevalence of Beta-Cell, Thyroid and Celiac Autoimmunity in North Indian Children with Recent Onset Type 1 Diabetes (T1D).

Authors:  Devi Dayal; Madhusudan Samprati; Navchetan Kaur; Ranjana Walker Minz; Dhaarani Jayaraman
Journal:  J Clin Diagn Res       Date:  2015-03-01

Review 4.  Insulin Allergy to Detemir Followed by Rapid Onset of Diabetic Ketoacidosis: A Case Report and Literature Review.

Authors:  Chong Boon Teo; Pek Yan Tan; Shan Xian Lee; Joan Khoo; Jun Guan Tan; Su Fen Ang; Sze Hwa Tan; Tunn Lin Tay; Eberta Tan; Su Chi Lim; Bernhard O Boehm; Wann Jia Loh
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-08       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.